Hypericum perforatum: Influences of the habitat on chemical composition, photo-induced cytotoxicity, and antiradical activity

Pharmaceutical Biology

Volumn 52, Issue 7, 2014, Pages 909-918

  Marrelli, Mariangela ^a   Conforti, Filomena ^a   Toniolo, Chiara ^b   Nicoletti, Marcello ^b   Statti, Giancarlo ^a   Menichini, Francesco ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti inflammatory; Antioxidant; HPTLC; Hypericin; Melanoma; Phenolic compounds; Phototoxicity

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ASCORBIC ACID; BERGAPTEN; BETA CAROTENE; BIAPIGENIN; CHLOROGENIC ACID; FLAVONOID; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; INDOMETACIN; NITRIC OXIDE; PHENOL DERIVATIVE; QUERCETIN; RUTOSIDE; UNCLASSIFIED DRUG; ANTIOXIDANT; NONSTEROID ANTIINFLAMMATORY AGENT; PERYLENE; PHOTOSENSITIZING AGENT; PLANT EXTRACT; SCAVENGER;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; ITALY; MACROPHAGE; METABOLOME; MOUSE; NONHUMAN; PHOTOTOXICITY; SPECIES HABITAT; ALTITUDE; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ECOSYSTEM; HYPERICUM; ISOLATION AND PURIFICATION; METABOLISM; PLANT; TUMOR CELL LINE;

ALTITUDE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CELL LINE, TUMOR; CELL SURVIVAL; ECOSYSTEM; FREE RADICAL SCAVENGERS; HUMANS; HYPERICUM; ITALY; MICE; NITRIC OXIDE; PERYLENE; PHENOLS; PHOTOSENSITIZING AGENTS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; RUTIN;

EID: 84902481890     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.872675     Document Type: Article

References (33)

1. Agostinis P, Vantieghem A, Merlevede W, de Witte PAM. (2002). Hypericin in cancer treatment: More light on the way. Int J Biochem Cell Biol 34:221-41.
2. Alecu M, Ursciuc C, Hãlãlãu F, et al. (1998). Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res 18:4651-4.
3. Barnes J, Anderson LA, Phillipson JD. (2001). St. John's wort (Hypericum perforatum L.): A review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 583-600.
4. Brockmoller J, Reum T, Bauer S, et al. (1997). Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30:94-101.
5. Carine MA, Christenhursk MJM. (2010). About this volume: The monograph of Hypericum by Norman Robson. Phytotaxa 4:1-4.
6. Chatterjee SS, Noldner M, Koch E, Erdelmeier C. (1998). Antidepressant activity of Hypericum perforatum and hyperforin: The neglected possibility. Pharmacopsychiatry 31:7-15.
7. Commission Nationale de Pharmacopée France. (1982). Pharmacopée française. 10th ed. Paris: Adrapharm.
8. Conforti F, Statti GA, Tundis R, et al. (2005). Comparative chemical composition and variability of biological activity of methanolic extracts from Hypericum perforatum L. Nat Prod Res 19:295-303.
9. Conforti F, Marrelli M, Colica C, et al. (2011). Bioactive phytonutrients (omega fatty acids, tocopherols, polyphenols), in vitro inhibition of nitric oxide production and free radical scavenging activity of noncultivated Mediterranean vegetables. Food Chem 129:1413-19.
10. Conforti F, Marrelli M, Statti G, et al. (2012). Comparative chemical composition and antioxidant activity of Calamintha nepeta (L.) Savi subsp. glandulosa (Req.) Nyman and Calamintha grandiflora (L.) Moench (Labiatae). Nat Prod Res 26:91-7.
11. Fernie WT. (1897). Herbal Simples. Bristol: John Wright.
12. Kapsokalyvas D, Dimitriou H, Skalkos D, et al. (2005). Does Hypericum perforatum L. extract show any speciEcity as photosensitizer for HL-60 leukemic cells and cord blood hemopoietic progenitors during photodynamic therapy? J Photochem Photobiol B Biol 80:208-16.
13. Kommission Deutscher Arzneimittel-Codex. (1986). Johanniskraut-Hyperici herba. DAC.
14. Kröncke KD, Fehsel K, Kolb-bachofen V. (1998). Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113:147-56.
15. Marrelli M, Menichini F, Statti GA, et al. (2012). Changes in the phenolic and lipophilic composition, in the enzyme inhibition and antiproliferative activity of Ficus carica L. cultivar Dottato fruits during maturation. Food Chem Toxicol 50:726-33.
16. Menichini G, Alfano C, Provenzano E, et al. (2012). Cachrys pungens Jan inhibits human melanoma cell proliferation through photoinduced cytotoxic activity. Cell Prol 45:39-47.
17. Muller WE, Singer A, Wonnemann M, et al. (1998). Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry 31:16-21.
18. Nahrstedt A, Butterweck V. (1997). Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 30:S129-34.
19. Nicoletti M. (2011a). HPTLC fingerprint: A modern approach for the analytical determination of botanicals. Rev Bras Farmacogn 21: 818-23.
20. Nicoletti M. (2011b). Isolation and identification of thiosildenafil in a health supplement. Nat Prod Commun 6:1003-4.
21. Nicoletti M, Petitto V, Gallo FR, et al. (2012). The modern analytical determination of botanicals and similar novel natural products by the HPTLC fingerprint approach. In: Atta-ur-Rahman, ed. Studies in Natural Products Chemistry. Oxford, UK: Elsevier, 217-57.
22. Pickering C. (1879). Chronological History of Plants. Boston: Little Brown.
23. Radulović N, Stankov-Jovanović V, Stojanović G, et al. (2007). Screening of in vitro antimicrobial and antioxidant activity of nine Hypericum species from the Balkans. Food Chem 103:15-21.
24. Sagratini G, Ricciutelli M, Vittori S, et al. (2008). Phytochemical and antioxidant analysis of eight Hypericum taxa from Central Italy. Fitoterapia 79:210-13.
25. Šavikin K, Dobrić S, Tadić V, Zdunić G. (2007). Anti-inflammatory activity of ethanol extracts of Hypericum perforatum L., H. barbatum Jacq., H. hirsutum L., H. richeri Vill. and H. androsaemum L. in rats. Phytoter Res 21:176-80.
26. Skalkos D, Gioti E, Stalikas C, et al. (2006). Photophysical properties of Hypericum perforatum L. extracts-Novel photosensitizers for PDT. J Photochem Photobiol B Biol 82:146-51.
27. Southwell IA, Bourke CA. (2001). Seasonal variation in hypericin content of Hypericum perforatum L. (St. John's wort). Phytochemistry 56:437-41.
28. Stavropoulos NE, Kim A, Nseyo UU, et al. (2006). Hypericum perforatum L. extract-Novel photosensitizer against human bladder cancer cells. J Photochem Photobiol B Biol 84:64-9.
29. Theodossiou TA, Hothersall JS, De Witte PA, et al. (2009). The multifaceted photocytotoxic profile of hypericin. Mol Pharm 6: 1775-89.
30. Upton R, Graff A, Williamson E, et al. (1997). American Herbal Pharmacopoeia and Therapeutic Compendium: St. John's wort (Hypericum perforatum). HerbalGram 40:S1-32.
31. Wagner H. (2004). Revival of pharmacognosy. Classical botanical pharmacognosy. Satellite symposium: Annual meeting of the American Society of Pharmacognosy, Phoenix, AZ.
32. Witte B, Harrer G, Kaptan T, et al. (1995). Treatment of depressive symptoms with a high concentration hypericum preparation. A multicenter placebo-controlled double-blind study. Fortschr Med 113:404-8.
33. Zdunić G, Godevac D, Milenković M, et al. (2009). Evaluation of Hypericum perforatum oil extracts for an anti-inflammatory and gastroprotective activity in rats. Phytother Res 23:1559-64.